Uni-Bio Science Group Limited (HKG:0690)

Uni-Bio Science Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	65.01	129.24	98.22	83.61	25.01
Short-Term Investments	118.89	12.36	10.4	6.72	15.62
Trading Asset Securities	-	-	-	-	36.03
Cash & Short-Term Investments	183.9	141.59	108.62	90.33	76.67
Cash Growth	29.88%	30.35%	20.26%	17.82%	-19.00%
Accounts Receivable	70.24	53.22	57.87	71.63	74.77
Other Receivables	0.19	0.59	-	-	13.49
Receivables	101.1	60.11	57.87	71.63	88.26
Inventory	33.78	36.39	33.85	39.71	16.52
Total Current Assets	318.78	238.1	200.34	201.67	181.44
Property, Plant & Equipment	138.34	104.08	59.87	57.45	62.32
Other Intangible Assets	2.24	2.67	3.09	3.81	4.1
Long-Term Deferred Tax Assets	4.12	3.85	0.43	-	-
Long-Term Deferred Charges	34.22	36.59	21.03	4.37	4.7
Other Long-Term Assets	19.44	15.47	7.71	0.3	0.17
Total Assets	517.55	409.99	292.47	267.59	252.72
Accounts Payable	15.23	9.31	5.27	5.26	3.83
Accrued Expenses	22.8	38.8	27.96	43.21	31.74
Short-Term Debt	5.26	8.86	0.13	-	-
Current Portion of Long-Term Debt	43.31	11.04	11.19	-	-
Current Portion of Leases	6.18	4.23	4.01	4.61	1.03
Current Income Taxes Payable	2.41	2.18	3.11	1.72	2.66
Current Unearned Revenue	17.67	25.16	21.81	20.21	13.18
Other Current Liabilities	10.64	15.22	16.78	17.29	7.93
Total Current Liabilities	123.5	114.79	90.26	92.3	60.37
Long-Term Debt	56.01	30.61	-	-	-
Long-Term Leases	9.7	6.99	7.47	0.99	2.11
Long-Term Unearned Revenue	0.26	-	-	-	-
Long-Term Deferred Tax Liabilities	2.45	0.43	-	-	0.83
Total Liabilities	191.91	152.82	97.73	93.29	63.31
Common Stock	59.71	63.65	63.65	63.5	63.91
Additional Paid-In Capital	725.69	751.76	751.76	750.77	754.89
Retained Earnings	-544.52	-628.48	-699.36	-737.87	-718.28
Treasury Stock	-	-5.17	-	-	-
Comprehensive Income & Other	84.76	75.42	78.7	97.91	88.89
Shareholders' Equity	325.65	257.17	194.75	174.31	189.41
Total Liabilities & Equity	517.55	409.99	292.47	267.59	252.72
Total Debt	120.45	61.73	22.8	5.6	3.14
Net Cash (Debt)	63.45	79.87	85.82	84.73	73.53
Net Cash Growth	-20.55%	-6.94%	1.29%	15.23%	-21.39%
Net Cash Per Share	0.01	0.01	0.01	0.01	0.01
Filing Date Shares Outstanding	5,971	6,279	6,365	6,350	6,391
Total Common Shares Outstanding	5,971	6,279	6,365	6,350	6,391
Working Capital	195.28	123.31	110.09	109.36	121.07
Book Value Per Share	0.05	0.04	0.03	0.03	0.03
Tangible Book Value	323.41	254.51	191.66	170.5	185.31
Tangible Book Value Per Share	0.05	0.04	0.03	0.03	0.03
Buildings	86.67	87.95	88.88	90.45	88.85
Machinery	160.98	118.54	117.24	127.38	122.8
Construction In Progress	41.11	54.56	5.81	2.09	2.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.